mCPP: an undesired addition to the ecstasy market

MG Bossong; Tibor M Brunt; J. Peter van Dijk; Sander  Rigter; Jani Hoek; Henk Goldschmidt; Raymond J M Niesink

doi:10.1177/0269881109102541

mCPP: an undesired addition to the ecstasy market

MG Bossong, Tibor M Brunt, J. Peter van Dijk, Sander Rigter, Jani Hoek, Henk Goldschmidt, Raymond J M Niesink

Brain

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

A new ecstasy-like substance, meta-chlorophenylpiperazine (mCPP), has been detected in street drugs in the Netherlands. Theoretically, mCPP possesses the potential to become a non-neurotoxic alternative for methylenedioxymethamphetamine (MDMA), the regular psychoactive substance of ecstasy. Since its introduction on the Dutch market of synthetic drugs, the percentage of mCPP-containing tablets has increased, including both tablets that contain only mCPP and tablets containing a combination of mCPP and MDMA. These tablets occur in many different colours, shapes and sizes and with various logos, making it impossible to distinguish mCPP-containing tablets from regular MDMA tablets. In addition, the reports of users concerning the effects of mCPP are predominantly negative. All these aspects together lead to the conclusion that mCPP is an undesired addition to the ecstasy market from the user's perspective.

Original language	English
Pages (from-to)	1395-1401
Number of pages	7
Journal	Journal of Psychopharmacology
Volume	24
Issue number	9
DOIs	https://doi.org/10.1177/0269881109102541
Publication status	Published - Sept 2010

Keywords

Drug Combinations
Gas Chromatography-Mass Spectrometry
Hallucinogens/adverse effects
Humans
Illicit Drugs/adverse effects
N-Methyl-3,4-methylenedioxyamphetamine/adverse effects
Netherlands
Piperazines/adverse effects

Access to Document

10.1177/0269881109102541

Cite this

@article{cad99eba53be4a63913b569decdebd86,

title = "mCPP: an undesired addition to the ecstasy market",

abstract = "A new ecstasy-like substance, meta-chlorophenylpiperazine (mCPP), has been detected in street drugs in the Netherlands. Theoretically, mCPP possesses the potential to become a non-neurotoxic alternative for methylenedioxymethamphetamine (MDMA), the regular psychoactive substance of ecstasy. Since its introduction on the Dutch market of synthetic drugs, the percentage of mCPP-containing tablets has increased, including both tablets that contain only mCPP and tablets containing a combination of mCPP and MDMA. These tablets occur in many different colours, shapes and sizes and with various logos, making it impossible to distinguish mCPP-containing tablets from regular MDMA tablets. In addition, the reports of users concerning the effects of mCPP are predominantly negative. All these aspects together lead to the conclusion that mCPP is an undesired addition to the ecstasy market from the user's perspective.",

keywords = "Drug Combinations, Gas Chromatography-Mass Spectrometry, Hallucinogens/adverse effects, Humans, Illicit Drugs/adverse effects, N-Methyl-3,4-methylenedioxyamphetamine/adverse effects, Netherlands, Piperazines/adverse effects",

author = "MG Bossong and Brunt, {Tibor M} and {van Dijk}, {J. Peter} and Sander Rigter and Jani Hoek and Henk Goldschmidt and Niesink, {Raymond J M}",

year = "2010",

month = sep,

doi = "10.1177/0269881109102541",

language = "English",

volume = "24",

pages = "1395--1401",

journal = "Journal of Psychopharmacology",

issn = "0269-8811",

publisher = "SAGE Publications Ltd",

number = "9",

}

TY - JOUR

T1 - mCPP

T2 - an undesired addition to the ecstasy market

AU - Bossong, MG

AU - Brunt, Tibor M

AU - van Dijk, J. Peter

AU - Rigter, Sander

AU - Hoek, Jani

AU - Goldschmidt, Henk

AU - Niesink, Raymond J M

PY - 2010/9

Y1 - 2010/9

N2 - A new ecstasy-like substance, meta-chlorophenylpiperazine (mCPP), has been detected in street drugs in the Netherlands. Theoretically, mCPP possesses the potential to become a non-neurotoxic alternative for methylenedioxymethamphetamine (MDMA), the regular psychoactive substance of ecstasy. Since its introduction on the Dutch market of synthetic drugs, the percentage of mCPP-containing tablets has increased, including both tablets that contain only mCPP and tablets containing a combination of mCPP and MDMA. These tablets occur in many different colours, shapes and sizes and with various logos, making it impossible to distinguish mCPP-containing tablets from regular MDMA tablets. In addition, the reports of users concerning the effects of mCPP are predominantly negative. All these aspects together lead to the conclusion that mCPP is an undesired addition to the ecstasy market from the user's perspective.

AB - A new ecstasy-like substance, meta-chlorophenylpiperazine (mCPP), has been detected in street drugs in the Netherlands. Theoretically, mCPP possesses the potential to become a non-neurotoxic alternative for methylenedioxymethamphetamine (MDMA), the regular psychoactive substance of ecstasy. Since its introduction on the Dutch market of synthetic drugs, the percentage of mCPP-containing tablets has increased, including both tablets that contain only mCPP and tablets containing a combination of mCPP and MDMA. These tablets occur in many different colours, shapes and sizes and with various logos, making it impossible to distinguish mCPP-containing tablets from regular MDMA tablets. In addition, the reports of users concerning the effects of mCPP are predominantly negative. All these aspects together lead to the conclusion that mCPP is an undesired addition to the ecstasy market from the user's perspective.

KW - Drug Combinations

KW - Gas Chromatography-Mass Spectrometry

KW - Hallucinogens/adverse effects

KW - Humans

KW - Illicit Drugs/adverse effects

KW - N-Methyl-3,4-methylenedioxyamphetamine/adverse effects

KW - Netherlands

KW - Piperazines/adverse effects

UR - http://journals.sagepub.com/doi/abs/10.1177/0269881109102541?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

U2 - 10.1177/0269881109102541

DO - 10.1177/0269881109102541

M3 - Article

C2 - 19304863

SN - 0269-8811

VL - 24

SP - 1395

EP - 1401

JO - Journal of Psychopharmacology

JF - Journal of Psychopharmacology

IS - 9

ER -

mCPP: an undesired addition to the ecstasy market

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this